Clinical utility of liquid biopsy for the diagnosis and monitoring of EML4-ALK NSCLC patients
Genomic rearrangement in anaplastic lymphoma kinase (ALK) gene occurs in 3−7% of patients with non-small-cell lung cancer (NSCLC). The detection of this alteration is crucial as ALK positive NSCLC patients benefit from ALK inhibitors, which improve both the patient's quality of life and overall...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN ES |
| Publicado: |
De Gruyter
2020
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/5adcc9d796aa44beae1ace9bc24a82b4 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|